Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
China
· Delayed Price · Currency is CNY 2.820
-0.090 (-3.09%)
Apr 28, 2025, 2:45 PM CST
SHE:002589 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 25, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 4,205 | 4,444 | 4,920 | 6,165 | 5,881 | 7,826 | Upgrade
|
| Market Cap Growth | -9.67% | -9.67% | -20.19% | 4.83% | -24.86% | -31.99% | Upgrade
|
| Enterprise Value | 5,957 | 7,022 | 3,501 | 7,785 | 11,382 | 10,805 | Upgrade
|
| Last Close Price | 2.81 | 2.97 | 3.25 | 4.09 | 3.89 | 5.16 | Upgrade
|
| PE Ratio | 205.11 | 215.52 | 242.17 | - | 44.83 | 29.95 | Upgrade
|
| Forward PE | - | 8.02 | 8.02 | 8.02 | 8.45 | 12.23 | Upgrade
|
| PS Ratio | 0.53 | 0.56 | 0.61 | 0.50 | 0.28 | 0.29 | Upgrade
|
| PB Ratio | 0.74 | 0.78 | 0.87 | 1.07 | 0.61 | 0.74 | Upgrade
|
| P/TBV Ratio | 0.85 | 0.90 | 1.04 | 1.33 | 0.91 | 1.23 | Upgrade
|
| P/FCF Ratio | 85.96 | 90.86 | - | 17.51 | - | - | Upgrade
|
| P/OCF Ratio | 26.21 | 27.70 | 59.67 | 11.79 | 13.28 | 18.86 | Upgrade
|
| PEG Ratio | - | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | Upgrade
|
| EV/Sales Ratio | 0.75 | 0.88 | 0.44 | 0.63 | 0.54 | 0.40 | Upgrade
|
| EV/EBITDA Ratio | 20.61 | 25.80 | 36.66 | 46.91 | 10.22 | 6.31 | Upgrade
|
| EV/EBIT Ratio | 78.13 | 92.09 | - | - | 13.99 | 7.60 | Upgrade
|
| EV/FCF Ratio | 121.78 | 143.54 | - | 22.11 | - | - | Upgrade
|
| Debt / Equity Ratio | 1.16 | 1.16 | 1.23 | 0.70 | 0.47 | 0.96 | Upgrade
|
| Debt / EBITDA Ratio | 22.76 | 22.76 | 69.19 | 22.86 | 4.01 | 5.87 | Upgrade
|
| Debt / FCF Ratio | 134.50 | 134.50 | - | 11.37 | - | - | Upgrade
|
| Asset Turnover | 0.49 | 0.49 | 0.46 | 0.55 | 0.72 | 0.84 | Upgrade
|
| Inventory Turnover | 7.65 | 7.65 | 6.96 | 7.07 | 6.92 | 6.80 | Upgrade
|
| Quick Ratio | 1.03 | 1.03 | 0.96 | 0.93 | 1.08 | 1.06 | Upgrade
|
| Current Ratio | 1.12 | 1.12 | 1.07 | 1.03 | 1.25 | 1.25 | Upgrade
|
| Return on Equity (ROE) | 0.72% | 0.72% | 0.56% | -22.52% | 3.78% | 6.02% | Upgrade
|
| Return on Assets (ROA) | 0.29% | 0.29% | -0.30% | -0.30% | 1.74% | 2.75% | Upgrade
|
| Return on Capital (ROIC) | 0.38% | 0.38% | -0.47% | -0.57% | 2.92% | 4.75% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.30% | 1.30% | - | - | 8.20% | 13.00% | Upgrade
|
| Earnings Yield | 0.49% | 0.46% | 0.41% | -29.70% | 2.23% | 3.34% | Upgrade
|
| FCF Yield | 1.16% | 1.10% | -4.39% | 5.71% | -0.31% | -2.88% | Upgrade
|
| Dividend Yield | 0.48% | - | 0.40% | - | 0.23% | 0.35% | Upgrade
|
| Payout Ratio | 963.58% | 963.58% | 992.70% | - | 241.13% | 132.63% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | -1.93% | -1.30% | -0.40% | 2.99% | Upgrade
|
| Total Shareholder Return | 0.47% | -0.01% | -1.53% | -1.30% | -0.17% | 3.34% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.